Published October 2025
Below is a recap of Medical Policy updates that went into effect recently. All policies are reviewed at least once annually. For more detailed information on the changes, please review our Provider FastFax Library or review all MVP Health Care Medical Policies.
Effective August 1, 2025
- Automatic External Defibrillator
- Blepharoplasty, Brow Lift, and Ptosis Repair
- Breast Pumps
- Cold Therapy Devices
- Hospital Beds
- Hyperhidrosis Treatments
- Imaging Procedures
- Implantable Cardioverter Defibrillators, Implantable Dual Chamber Automatic Defibrillators, Cardiac Resynchronization Devices
- Intraoperative Neurophysiologic Monitoring During Spinal Surgery
- Mental Health Services
- Orthotic Devices (other than therapeutic diabetic footwear)
- Sacral Nerve Stimulation and Percutaneous Nerve Stimulation
Effective October 1, 2025
- Assertive Community Treatment (ACT)
- Autologous Chondrocyte Implantation, Osteochondral Allograft Transplantation, Osteochondral Autograft Transfer System (OATS)
- Endometrial Ablation
- Hyperbaric Oxygen Therapy (HBO) and Topical Oxygen Therapy
- Light Therapy for Seasonal Affective Disorder
- Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture
- Power Mobility Devices
- Transplants
- Treatment for Addictions
- Varicose Vein Treatment
- Vision Therapy (Orthoptics, Eye Exercises)
Policy Updates
Review other articles in this issue regarding formulary, pharmacy policy, and medical policy updates.